Digital healthcare company Babylon Health has acquired US-based consumer health engagement company Higi Health.
Dr. Ali Parsa, CEO of Babylon, said the partnership with Higi, which offers biometric self-screening health stations located within five miles of 73 per cent of the population, will help the London-based Babylon extend its reach in the US.
“Our mission is to make quality healthcare accessible and affordable for every person, irrespective of the lottery of the geographic location, economic status or social hierarchy in which they find themselves.
“Our partnership with Higi will help us extend the range and reach of our services across the United States. We have known Higi’s executives, board and investors for a long time and share common values with them.”
The combined company will also provide a more holistic, end-to-end solution to meet the needs of payers, providers and retailers on the front lines of care delivery.
As remote patient monitoring continues to grow in necessity over the course of the pandemic, this acquisition will allow Babylon to extend its technology platform and digital-first healthcare solutions to millions of existing Higi customers, some of whom live in areas where access to healthcare has been previously out of reach.
Jeff Bennett, CEO of Higi said this will be an especially valuable integration for consumers managing chronic conditions in rural communities.
“Our commitment has always been to make it easy and convenient for everyone to be their healthiest.
“Higi has partnered with healthcare leaders across retailers, health plans, providers and NGOs to meet consumers where they are in their healthcare journey and provide equitable access to insights and navigation to products and services to improve their health.
“As one company, we will deliver so much more, and alongside Babylon, we are excited to continue our work to bring affordable, accessible healthcare to all.”
This acquisition follows Babylon’s initial strategic investment in Higi in early 2020, which led the company’s Series B funding round.
